>Q13772_Disorder
1-16, 207-225, 243-253, 271-275, 314-319, 345-358, 437-455, 499-533, 541-551, 576-588
MNTFQDQSGS SSNREPllrc sdarrdlela iggvlraeqq ikdnlrevka qihscisrhl eclrsrevwl yeqvdliyql keetlqqqaq qlysllgqfn clthqlectq nkdlanqvsv clerlgsltl kpedstvllf eadtitlrqt ittfgslkti qipehlmaha ssanigpfle krgcismpeq ksasgivavp fsewllGSKP ASGYQAPYIP STDPQdwltq kqtlensqts srACNFFNNV GGNlkglenw llksekssyq KCNSHsttss fsiemekvgd qelpdqdemd lsdwlvtpqe shkLRKPENg sretsekfkl lfqsynvndw lvktDSCTNC QGNQPKGVei enlgnlkcln dhleakkpls tpsmvtedwl vqnhqdpckv eevcranepc tsfaecvcde ncekealykw llkkegKDKN GMPVEPKPEP EKHKDslnmw lcprkevieq tkapkamtps riadsfqvik nsplsewlIR PPYKEGSPKE VPGTEDRAGK QKFKSPMNTS WCSfntadwv LPGKKMGNLS Qlssgedkwl lrkkaqevll nsplqEEHNF PPDHYGLPav cdlfacmqlk vdkekwlyrt plqm
>Q13772_GlobDoms
3-206, 226-344, 359-436, 532-614
mnTFQDQSGS SSNREPLLRC SDARRDLELA IGGVLRAEQQ IKDNLREVKA QIHSCISRHL ECLRSREVWL YEQVDLIYQL KEETLQQQAQ QLYSLLGQFN CLTHQLECTQ NKDLANQVSV CLERLGSLTL KPEDSTVLLF EADTITLRQT ITTFGSLKTI QIPEHLMAHA SSANIGPFLE KRGCISMPEQ KSASGIVAVP FSEWLLgskp asgyqapyip stdpqDWLTQ KQTLENSQTS SRACNFFNNV GGNLKGLENW LLKSEKSSYQ KCNSHSTTSS FSIEMEKVGD QELPDQDEMD LSDWLVTPQE SHKLRKPENG SRETSEKFKL LFQSYNVNDW LVKTdsctnc qgnqpkgvEI ENLGNLKCLN DHLEAKKPLS TPSMVTEDWL VQNHQDPCKV EEVCRANEPC TSFAECVCDE NCEKEALYKW LLKKEGkdkn gmpvepkpep ekhkdslnmw lcprkevieq tkapkamtps riadsfqvik nsplsewlir ppykegspke vpgtedragk qkfkspmnts wCSFNTADWV LPGKKMGNLS QLSSGEDKWL LRKKAQEVLL NSPLQEEHNF PPDHYGLPAV CDLFACMQLK VDKEKWLYRT PLQM
JOB-ID: | Q13772_025459ZixpA38AAAEAAFLU5kEAAACC |
---|---|
Paramters: | propensities=Russell/Linding smooth=10 dy/dx_smooth=10 |
Disorder frames: | peak-frame=5 join-frame=4 |
Globularity frames: | peak-frame=74 join-frame=15 |
Name: | Q13772 |
Description: | sp|Q13772|NCOA4_HUMAN Nuclear receptor coactivator 4 OS=Homo sapiens OX=9606 GN=NCOA4 PE=1 SV=1 |
Plot title/ID: | none |
Sequence length: | 614 |
Download Results | smoothed raw dydx |